Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Problems induced by meta-analyses.

T C Chalmers1

  • 1Technology Assessment Group, Harvard School of Public Health, Boston, MA 02115.

Statistics in Medicine
|June 1, 1991
PubMed
Summary
This summary is machine-generated.

Meta-analyses of randomized trials are increasing rapidly. Statisticians and policymakers face challenges in evaluating trial quality, handling data heterogeneity, and updating these crucial evidence syntheses.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

COMMUNITY HOSPITAL DEVELOPMENT PROGRAM IN RESEARCH TRAINING.

A listing of research in the cardiovascular field·2014
Same author

A study of 40 patients who died in liver coma.

The Journal of clinical investigation·2010
Same author

The effectiveness of glucocorticoids in treating croup: meta-analysis.

The Western journal of medicine·2008
Same author

Omeprazole plus antibiotics in the eradication of Helicobacter pylori infection: a meta-regression analysis of randomized, controlled trials.

American journal of therapeutics·1999
Same author

Are randomized control trial outcomes influenced by the inclusion of a placebo group?: a systematic review of nonsteroidal antiinflammatory drug trials for arthritis treatment.

Journal of clinical epidemiology·1999
Same author

Safety of nifedipine in angina pectoris: a meta-analysis.

Hypertension (Dallas, Tex. : 1979)·1999
Same journal

Interpretable Bayesian Modeling for Multireader Multicase Studies: Addressing Overdispersion and Limited Sample Size in Diagnostic Enhancement Evaluation.

Statistics in medicine·2026
Same journal

Adaptive Sequential Multiple Hypotheses Testing for Concomitant Vaccine Safety Surveillance.

Statistics in medicine·2026
Same journal

Novel Distance Regression for Repeated Outcomes With Missing Data: Applications to Longitudinal and Crossover Studies of Microbiome Beta-Diversity.

Statistics in medicine·2026
Same journal

Optimal Weighted Tests for Replication Studies and the 'Two-Trials Rule' With Multiple Hypotheses.

Statistics in medicine·2026
Same journal

Identifiable Copula-Double-Cox Models: A Fully Parametric Framework for Dependent Right-Censored Survival Data.

Statistics in medicine·2026
Same journal

Moving From Individualized Risk-Based Prevention to Benefit-Based Prevention: Estimating Individualized Life-Years Gained From Prevention Services as a Basis for Eligibility.

Statistics in medicine·2026
See all related articles

Area of Science:

  • Biostatistics
  • Clinical Epidemiology
  • Health Services Research

Background:

  • Over 150 meta-analyses of randomized controlled trials (RCTs) exist, with >15 new ones annually.
  • The rapid growth of meta-analysis presents challenges for statistical methods and healthcare policy.
  • Ensuring the quality of original trials and avoiding retrospective research pitfalls is critical.

Purpose of the Study:

  • To address the statistical and policy challenges posed by the increasing number of meta-analyses.
  • To highlight the importance of evaluating the quality of primary randomized controlled trials.
  • To discuss methods for handling heterogeneity in control event rates and treatment effects.

Main Methods:

  • Statistical evaluation of heterogeneity in control event rates and treatment differences.

Related Experiment Videos

  • Assessment of the quality of individual randomized controlled trials.
  • Consideration of methods for updating meta-analyses as new data emerge.

    • Main Results:

    • The proliferation of meta-analyses necessitates robust statistical approaches.
    • Quality assessment of included trials is paramount for reliable evidence synthesis.
    • Statistical methods are required to manage heterogeneity and ensure timely updates.

    Conclusions:

    • Effective management of meta-analyses requires careful attention to trial quality and statistical methods.
    • Addressing heterogeneity and updating evidence syntheses are key challenges.
    • The increasing volume of meta-analyses impacts clinical medicine evaluation and health policy decisions.